The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(RS)-(4,4-difluoro-3-(quinolin-2-yloxy)piperidin-1-yl)(4-fluorophenyl)methanone ID: ALA3979157
PubChem CID: 134151826
Max Phase: Preclinical
Molecular Formula: C21H17F3N2O2
Molecular Weight: 386.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccc(F)cc1)N1CCC(F)(F)C(Oc2ccc3ccccc3n2)C1
Standard InChI: InChI=1S/C21H17F3N2O2/c22-16-8-5-15(6-9-16)20(27)26-12-11-21(23,24)18(13-26)28-19-10-7-14-3-1-2-4-17(14)25-19/h1-10,18H,11-13H2
Standard InChI Key: VKQHUBNARZWDMS-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
17.1940 -0.7058 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.6068 -1.4156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0152 -0.7033 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.5046 -4.2923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5034 -5.1118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2115 -5.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2097 -3.8834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9183 -4.2887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9217 -5.1139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6273 -3.8709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3386 -4.2732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6200 -3.0537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3245 -2.6368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3192 -1.8232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9038 -1.8307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9075 -2.6505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0247 -1.4108 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7346 -1.8157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7338 -2.6301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4428 -3.0349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4328 -1.4001 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1424 -1.8012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1453 -2.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8540 -3.0236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5601 -2.6115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5532 -1.7905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8440 -1.3896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7954 -5.5199 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 10 1 0
10 11 2 0
10 12 1 0
12 13 1 0
12 16 1 0
13 14 1 0
14 2 1 0
2 15 1 0
15 16 1 0
14 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 23 2 0
22 21 2 0
21 18 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
5 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.37Molecular Weight (Monoisotopic): 386.1242AlogP: 4.30#Rotatable Bonds: 3Polar Surface Area: 42.43Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.22CX LogP: 4.67CX LogD: 4.67Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.67Np Likeness Score: -1.14
References 1. Stump CA, Cooke AJ, Bruno J, Cabalu TD, Gotter AL, Harell CM, Kuduk SD, McDonald TP, O'Brien J, Renger JJ, Williams PD, Winrow CJ, Coleman PJ.. (2016) Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology., 26 (23): [PMID:27818110 ] [10.1016/j.bmcl.2016.10.019 ]